Compare Honeywell International Inc (HON) vs Nomura Holdings Inc (NMR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Honeywell International Inc vs Nomura Holdings Inc — how do they compare? Honeywell International Inc trades at $207.73 (market cap $65.48B), while Nomura Holdings Inc trades at $9.59 (market cap $27.55B). The key difference: Honeywell International Inc is far larger — about 2.4× Nomura Holdings Inc's market cap, and Nomura Holdings Inc pays the higher dividend (3.4%). Which is the better fit depends on your goals — on Pluang, investors hold Honeywell International Inc for 91 Days and Nomura Holdings Inc for 55 Days on average.
| HON | NMR | |
|---|---|---|
Market Cap | $65.48B | $27.55B |
Volume | 2,047,782 | 782,470 |
Sector | Industrials | Financials |
52-Week High | $248.79 | $10.86 |
52-Week Low | $188.14 | $6.73 |
Typical Hold Time | 91 Days | 55 Days |
Enterprise Value | $90.27B | $38.54T |
Dividend Yield | 1.36% | 3.4% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Honeywell International (HON) trades at $206.6, down 0.73% with bearish technical signals despite strong fundamental metrics including a low P/E of 7.94 and robust ROE of 47.43%. The company recently beat Q2 2026 EPS estimates and secured a $300 million refinery project, positioning for growth post-spinoff of its aerospace and advanced materials divisions. Analyst consensus remains strongly bullish with a $259.25 price target.
HON presents a compelling value opportunity with attractive valuation multiples and consistent earnings outperformance, though near-term technical weakness and increasing debt-to-asset ratios warrant caution. The company's strategic focus on automation and recent contract wins support long-term growth prospects despite cyclical industrial sector risks.
Nomura Holdings (NMR) trades at $9.54, up 0.1% on the day, with a bearish technical signal but strong fundamental metrics including a P/E of 11.33 and net income margin of 20.4%. Recent earnings show a mix of beats and misses, while cash flow trends indicate significant financing activity. The stock is near its support level of $9, with RSI indicators suggesting potential oversold conditions. Zacks Research highlighted NMR as a strong buy for momentum and value in September 2026, citing recent price strength.
The outlook for NMR is cautiously optimistic, supported by solid profitability and valuation, but tempered by bearish technicals and inconsistent earnings performance. Key risks include high debt levels and macroeconomic sensitivity, while analyst sentiment leans hold. Upside potential exists if earnings stabilize and technical support holds.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Honeywell International Inc
Honeywell is a global multi-industry behemoth with one of the largest installed bases of equipment. The firm operates through four business segments, including aerospace, building technologies, performance materials and technologies, and safety and productivity solutions. In recent years, the firm has made several portfolio changes, including the addition of Intelligrated in 2016, as well as the spins of Garrett Technologies and Resideo in 2018.
Read more on HON →About Nomura Holdings Inc
Nomura is Japan's largest broker, about twice the size of rival Daiwa Securities and roughly three times the size of the securities units of the three megabanks. It is also the largest asset-management company in Japan, with a similar size differential compared with its rivals. Despite its topnotch brand name in retail broking and asset management in Japan, Nomura has struggled to compete effectively in the institutional securities business against larger global rivals. In 2008, Nomura bought European and Asian assets of the failed Lehman Brothers, which led to a sharply higher cost base but did not provide commensurate revenue. Nomura has reduced the scale of these businesses but maintains its ambition to compete globally with the top players.
Read more on NMR →
